Reactive oxygen species mediated apoptosis of esophageal cancer cells induced by marine triprenyl toluquinones and toluhydroquinones

• Published in: Molecular cancer therapeutics Vol. 6; no. 9; pp. 2535 - 2543
• Main Authors: Whibley, Catherine E., McPhail, Kerry L., Keyzers, Robert A., Maritz, Michelle F., Leaner, Virna D., Birrer, Michael J., Davies-Coleman, Michael T., Hendricks, Denver T.
• Format: Journal Article
• Language: English
• Published: United States American Association for Cancer Research 01.09.2007
• Subjects: Animals; Apoptosis - drug effects; Blotting, Western; Cell Cycle - drug effects; Cell Proliferation - drug effects; Cells, Cultured; chemotherapy; esophageal cancer; Esophageal Neoplasms - drug therapy; Esophageal Neoplasms - metabolism; Esophageal Neoplasms - pathology; Free Radical Scavengers - pharmacology; Humans; Hydroquinones - chemistry; Hydroquinones - pharmacology; Leminda millecra; Mitogen-Activated Protein Kinases - metabolism; Mollusca - chemistry; Necrosis; Proto-Oncogene Proteins c-jun - metabolism; quinones; Quinones - chemistry; Quinones - pharmacology; reactive oxygen species; Reactive Oxygen Species - metabolism
• ISSN: 1535-7163; 1538-8514
• DOI: 10.1158/1535-7163.MCT-06-0760

Marine invertebrates, algae, and microorganisms are prolific producers of novel secondary metabolites. Some of these secondary metabolites have the potential to be developed as chemotherapeutic agents for the treatment of a wide variety of diseases, including cancer. We describe here the mechanism leading to apoptosis of esophageal cancer cell lines in the presence of triprenylated toluquinones and toluhydroquinones originally isolated from the Arminacean nudibranch Leminda millecra . Triprenylated toluquinone–induced and toluhydroquinone-induced cell death is mediated via apoptosis after a cell cycle block. Molecular events include production of reactive oxygen species (ROS), followed by induction and activation of c-Jun (AP1) via c-Jun-NH 2 -kinase–mediated and extracellular signal-regulated kinase–mediated pathways. Partial resistance to these compounds could be conferred by the ROS scavengers Trolox and butylated hydroxyanisol, a c-Jun-NH 2 -kinase inhibitor, and inhibition of c-Jun with a dominant negative mutant (TAM67). Interestingly, the levels of ROS produced varied between compounds, but was proportional to the ability of each compound to kill cells. Because cancer cells are often more susceptible to ROS, these compounds present a plausible lead for new antiesophageal cancer treatments and show the potential of the South African marine environment to provide new chemical entities with potential clinical significance. [Mol Cancer Ther 2007;6(9):2535–43]